Actualidad Basada en la Investigación del Cáncer

Guadalajara, Jalisco 44680

0 studies enrolling now · 4 studies all time

What they study most

Abiraterone Acetate, Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation, Androgens, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Cytochrome P-450, Enzyme Inhibitors, Hormones

Studies at this site

• REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) — Running, not enrolling
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) — Running, not enrolling
• A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants — Completed